MOSCOW — Russia’s 3D ultrasound equipment market is expected to grow at a compound annual rate of 4.7% through 2035, according to a new analysis by IndexBox, as the country seeks to modernize its healthcare infrastructure despite Western sanctions. The report suggests domestic manufacturers may capture up to 35% of the market by 2026, up from 22% in 2022, as import substitution policies take effect.
Analysts attribute the projected growth to two key factors: Russia’s aging population requiring more diagnostic imaging and government initiatives to replace foreign-made medical equipment. “The maternity care segment alone will drive 28% of demand,” noted a healthcare industry source familiar with the report who requested anonymity due to commercial sensitivities.
Market dynamics have shifted dramatically since 2022, when U.S. and EU sanctions restricted exports of advanced medical imaging technology to Russia. Chinese manufacturers like Mindray and Edan Instruments have filled part of the gap, with their combined market share growing from 9% to 17% in the past two years, according to customs data reviewed by SourceRated.
However, skepticism remains about Russia’s ability to develop competitive domestic alternatives. “The precision engineering required for high-end ultrasound systems still largely depends on imported components,” said Dr. Elena Petrova, a medical technology analyst at Moscow State University. “Current localization efforts are focused on assembly rather than full production.”
The report’s long-term projections assume stable government healthcare funding — a potential vulnerability given Russia’s military expenditures. Should economic pressures intensify, experts warn the private healthcare sector may bear the brunt of equipment shortages, potentially widening disparities in medical access across regions.